Cardiology Devices - EMEA

  • EMEA
  • The Cardiology Devices market market in the Europe, Middle East, and Africa (in Europe, the Middle East, and Africa) region is anticipated to achieve a revenue of US$25.46bn by the year 2024.
  • This projection signifies a positive growth trend, with an estimated annual growth rate (CAGR 2024-2029) of 5.53%.
  • Consequently, the market volume is expected to expand to US$33.32bn by 2029.
  • When considering the global perspective, the United States is predicted to generate the highest revenue in the Cardiology Devices market market, reaching US$25,770.00m in 2024.
  • In the EMEA region, Germany leads the way in the adoption of innovative cardiology devices, with a strong emphasis on precision and efficiency.

Key regions: United Kingdom, United States, France, Spain, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cardiology Devices market in EMEA is experiencing significant growth and development. Customer preferences in the Cardiology Devices market in EMEA are driven by the increasing prevalence of cardiovascular diseases, rising geriatric population, and advancements in technology. Patients are seeking minimally invasive procedures and innovative devices that offer better outcomes and faster recovery times. Additionally, there is a growing demand for personalized medicine, with patients expecting tailored treatment plans and devices that cater to their specific needs. Trends in the market include the adoption of remote monitoring devices, which allow healthcare professionals to monitor patients' cardiac health remotely and make timely interventions. This trend is particularly prominent in rural areas where access to healthcare facilities is limited. Another trend is the integration of artificial intelligence and machine learning algorithms into cardiology devices, enabling more accurate diagnosis and treatment planning. Additionally, there is a shift towards the use of bioresorbable stents, which gradually dissolve in the body and eliminate the need for long-term medication. Local special circumstances in the Cardiology Devices market in EMEA vary across countries. In some countries, there is a lack of healthcare infrastructure and trained professionals, leading to limited access to cardiology devices and services. On the other hand, certain countries have well-established healthcare systems and high levels of healthcare expenditure, driving the adoption of advanced cardiology devices. Cultural factors also play a role, with some countries having a higher acceptance of new technologies and willingness to adopt innovative cardiology devices. Underlying macroeconomic factors contributing to the development of the Cardiology Devices market in EMEA include the increasing healthcare expenditure, favorable reimbursement policies, and government initiatives to improve healthcare infrastructure. Additionally, the growing awareness about the importance of early diagnosis and treatment of cardiovascular diseases is driving the demand for cardiology devices. Economic growth and rising disposable incomes in some countries are also enabling patients to afford expensive cardiology devices and procedures. In conclusion, the Cardiology Devices market in EMEA is witnessing significant growth and development driven by customer preferences for minimally invasive procedures, personalized medicine, and innovative devices. The adoption of remote monitoring devices and integration of artificial intelligence are notable trends in the market. Local special circumstances and underlying macroeconomic factors vary across countries, influencing the adoption and development of cardiology devices.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)